Traynor Capital Management, Inc. - PDL BIOPHARMA INC ownership

Back to all holdings Add to watchlist

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 186 filers reported holding PDL BIOPHARMA INC in Q3 2017. The put-call ratio across all filers is 1.44 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Traynor Capital Management, Inc. ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q3 2017$51,000
+41.7%
15,0000.0%0.02%
+33.3%
Q2 2017$36,000
+12.5%
15,0000.0%0.02%0.0%
Q1 2017$32,000
-63.6%
15,000
-47.4%
0.02%
-73.9%
Q2 2016$88,000–28,534–0.07%–
 Download
Other shareholders
PDL BIOPHARMA INC shareholders Q3 2017
NameSharesValueWeighting ↓
Argent Trust Co 41,405$102,2700.01%
Diversified Trust Co 11,029$26,4690.00%
HANCOCK WHITNEY CORP 128,396$00.00%
RHUMBLINE ADVISERS 612$1,5110.00%
Ancora Advisors LLC 4,948$00.00%
Westside Investment Management, Inc. 500$00.00%
View complete list of PDL BIOPHARMA INC shareholders